Atenolol
- Product NDC
- 0615-3544
- 11-digit product format
- 006153544
- Labeler code
- 0615
- Product ID
- 0615-3544_a340ebdc-4eb9-4ee2-8f14-5fb61bb9356e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA074052
- Marketing category
- ANDA
- Marketing start
- 1992-05-01
- Marketing end
- 0000-00-00
- Substance
- ATENOLOL
- Active strength
- 25 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-3544-05 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |
| 0615-3544-30 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |
| 0615-3544-31 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |
| 0615-3544-39 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |
| 0615-3544-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |
| 0615-3544-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |
| 0615-3544-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |
| 0615-3544-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-15cf-f424-e053-dadaa90a57ce | 78470162-0f92-4f46-a9c8-902f94ddcc7f |